BioNxt Settles Debt with Share and Cash Agreement

BioNxt Solutions Inc. has announced a debt settlement agreement with a non-affiliated creditor to address a debt totaling $225,010. Under the terms of the settlement, BioNxt will issue 112,505 common shares at CAD$1.00 per share and make a cash payment of $112,505 to settle the debt fully.

The newly issued shares will be under a four-month and one-day hold period as per Canadian Securities Exchange (CSE) policies. The completion of this transaction is contingent on regulatory approvals, including that of the CSE.

The company's measures reflect its strategic financial management, aiming to balance obligations with growth aspirations, although no assurance is provided concerning the regulatory approval process outcomes.